What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Virus
- Disease
Maria Buti focuses on Internal medicine, Gastroenterology, Hepatitis B, Hepatitis B virus and Immunology.
The study incorporates disciplines such as Lamivudine and Ribavirin in addition to Internal medicine.
Her Gastroenterology research is multidisciplinary, incorporating elements of Surgery and Combination therapy.
Her biological study spans a wide range of topics, including Viral hepatitis, Viral load, Adefovir, Reverse-transcriptase inhibitor and Entecavir.
Her Hepatitis B virus study is concerned with the larger field of Virology.
The various areas that Maria Buti examines in her Virology study include Antibody and Genotype, Hepatitis E virus.
Her most cited work include:
- EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. (1745 citations)
- Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection (1320 citations)
- Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study (1040 citations)
What are the main themes of her work throughout her whole career to date?
Her scientific interests lie mostly in Internal medicine, Virology, Gastroenterology, Hepatitis B virus and Hepatitis B.
Her research integrates issues of Chronic hepatitis, Ribavirin and Immunology in her study of Internal medicine.
Her Genotype research extends to Virology, which is thematically connected.
Her work on Liver disease as part of general Gastroenterology study is frequently linked to In patient, therefore connecting diverse disciplines of science.
Maria Buti has researched Hepatitis B in several fields, including Entecavir and Viral hepatitis.
As a part of the same scientific family, Maria Buti mostly works in the field of Cirrhosis, focusing on Hepatocellular carcinoma and, on occasion, Incidence.
She most often published in these fields:
- Internal medicine (55.54%)
- Virology (42.91%)
- Gastroenterology (38.24%)
What were the highlights of her more recent work (between 2018-2021)?
- Internal medicine (55.54%)
- Gastroenterology (38.24%)
- Hepatitis B virus (28.55%)
In recent papers she was focusing on the following fields of study:
Her primary scientific interests are in Internal medicine, Gastroenterology, Hepatitis B virus, Hepatitis B and HBsAg.
Her studies in Internal medicine integrate themes in fields like Entecavir and Chronic hepatitis.
Her work deals with themes such as Liver transplantation, Hepatitis C, Adverse effect, Sofosbuvir and Cohort, which intersect with Gastroenterology.
Hepatitis B virus is a subfield of Virology that Maria Buti investigates.
Her Hepatitis B research is multidisciplinary, relying on both Liver disease, Disease, Viral replication, Chronic infection and Elevated transaminases.
The concepts of her HBsAg study are interwoven with issues in Viral hepatitis, Randomized controlled trial, Cumulative incidence, Confidence interval and Pegylated interferon.
Between 2018 and 2021, her most popular works were:
- Genomewide Association Study of Severe Covid-19 with Respiratory Failure. (594 citations)
- Factors Associated With Rates of HBsAg Seroclearance in Adults With Chronic HBV Infection: A Systematic Review and Meta-analysis (55 citations)
- Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference‡ (44 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Virus
- Disease
Maria Buti spends much of her time researching Internal medicine, Gastroenterology, Hepatitis B virus, Cirrhosis and Hepatocellular carcinoma.
Internal medicine and HBsAg are commonly linked in her work.
Her work in Gastroenterology addresses subjects such as Chronic hepatitis, which are connected to disciplines such as Clinical trial and Tenofovir.
Her Hepatitis B virus research includes themes of Tolerability and Hepatitis C virus.
Maria Buti focuses mostly in the field of Cirrhosis, narrowing it down to topics relating to Liver transplantation and, in certain cases, Quality of life, Proportional hazards model and Disease.
Her Hepatocellular carcinoma study incorporates themes from Entecavir and Liver disease.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
